Douglas Cubbin
Chairman at ONCOSIL MEDICAL LIMITED
Profile
Douglas Cubbin is currently the Co-Chief Executive Officer at Telix Pharmaceuticals SAS, the Non-Executive Chairman at OncoSil Medical Ltd., a Director at Advanced Nuclear Medicine Ingredients SA, and a Member of the Australian Institute of Co. Directors.
Previously, he served as the Chairman at ANSTO Nuclear Medicine Pty Ltd., the General Manager-Business Development at the Australian Nuclear Science & Technology Organisation, and the Group Chief Financial Officer at DHL Global Forwarding (Australia) Pty Ltd.
He also held the position of Group Chief Financial Officer at Telix Pharmaceuticals Ltd.
from 2017 to 2022.
Douglas Cubbin active positions
| Companies | Position | Start |
|---|---|---|
| ONCOSIL MEDICAL LIMITED | Chairman | 2023-08-30 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Advanced Nuclear Medicine Ingredients SA
 Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Advanced Nuclear Medicine Ingredients SA engages in the distribution of pharmaceutical ingredients. Its products and services include toward cold kits for PET, custom peptide synthesis, new theranostic cold kits and theranostic development. The company was founded by Bruno Colard, Severine Plunus, Laurent Bodson, Monique Body, Amadeo Falcone, Sabine Lurson, Gael Minon, Michel Falcone, Vanessa Charlier, Chantal Riviere, Jean Francois Kaisin, Samuel Voccia, and Ludovic Wouters on March 27, 2015 and is headquartered in Liege, Belgium. | Director/Board Member | 2018-12-20 |
Telix Pharmaceuticals SAS
 Telix Pharmaceuticals SAS BiotechnologyHealth Technology Telix Pharmaceuticals SAS engages in the pharmaceutical industry. It provides research in biotechnology. The company was founded on July 25, 2008 and is headquartered in Nantes, France. | Chief Executive Officer | 2018-09-27 |
Former positions of Douglas Cubbin
| Companies | Position | End |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Director of Finance/CFO | 2022-07-30 |
| Australian Nuclear Science & Technology Organisation | Corporate Officer/Principal | - |
| ANSTO Nuclear Medicine Pty Ltd. | Chairman | - |
DHL Global Forwarding (Australia) Pty Ltd.
 DHL Global Forwarding (Australia) Pty Ltd. Air Freight/CouriersTransportation Part of Deutsche Post AG, DHL Global Forwarding (Australia) Pty Ltd. is an Australian company that provides freight transportation arrangement services. The private company is based in Northern Territory, Australia. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ONCOSIL MEDICAL LIMITED | Health Technology |
| TELIX PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 6 |
|---|---|
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
| Australian Nuclear Science & Technology Organisation | |
DHL Global Forwarding (Australia) Pty Ltd.
DHL Global Forwarding (Australia) Pty Ltd. Air Freight/CouriersTransportation Part of Deutsche Post AG, DHL Global Forwarding (Australia) Pty Ltd. is an Australian company that provides freight transportation arrangement services. The private company is based in Northern Territory, Australia. | Transportation |
Telix Pharmaceuticals SAS
Telix Pharmaceuticals SAS BiotechnologyHealth Technology Telix Pharmaceuticals SAS engages in the pharmaceutical industry. It provides research in biotechnology. The company was founded on July 25, 2008 and is headquartered in Nantes, France. | Health Technology |
Advanced Nuclear Medicine Ingredients SA
Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Advanced Nuclear Medicine Ingredients SA engages in the distribution of pharmaceutical ingredients. Its products and services include toward cold kits for PET, custom peptide synthesis, new theranostic cold kits and theranostic development. The company was founded by Bruno Colard, Severine Plunus, Laurent Bodson, Monique Body, Amadeo Falcone, Sabine Lurson, Gael Minon, Michel Falcone, Vanessa Charlier, Chantal Riviere, Jean Francois Kaisin, Samuel Voccia, and Ludovic Wouters on March 27, 2015 and is headquartered in Liege, Belgium. | Distribution Services |
| ANSTO Nuclear Medicine Pty Ltd. |
- Stock Market
- Insiders
- Douglas Cubbin
